Effector Therapeutics Company
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Founded Date: 2012
Employees Number: 11-50
Estimated Revenue: $10M to $50M
Register and Claim Ownership